Flexible Bioelectronic Innovation for Personalized Health Management
March 2023
in “
Cancer Innovation
”
Flexible bioelectronics (FBEs) emerged as innovative tools in personalized health management, particularly in cancer therapy, by providing non-invasive monitoring and treatment options. These devices, which integrate sensors with the human body, offered real-time health data collection and disease intervention through nonpharmacological methods like photothermal and photodynamic therapies. Despite their potential, FBEs faced challenges in material stability, biocompatibility, and multi-signal processing. They showed promise in early cancer detection and treatment by integrating diagnosis and therapy, but further advancements were needed to enhance their robustness and effectiveness for clinical applications.